{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:56:25Z","timestamp":1762210585075},"reference-count":38,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2069,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1751-7141.2009.00063.x","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T17:05:17Z","timestamp":1263315917000},"source":"Crossref","is-referenced-by-count":6,"title":["A Randomized Clinical Trial to Assess the Effect of Statins on Skeletal Muscle Function and Performance: Rationale and Study Design"],"prefix":"10.1111","author":[{"given":"Paul D.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla M.","family":"Clarkson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Pescatello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Michael White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin D.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"issue":"19","key":"10.1111\/j.1751-7141.2009.00063.x-BIB1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1111\/j.1751-7141.2009.00063.x-BIB3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7141.2009.00063.x-BIB4","author":"Physician's Desk Reference, Inc","year":"2002"},{"issue":"7","key":"10.1111\/j.1751-7141.2009.00063.x-BIB5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1111\/j.1751-7141.2009.00063.x-BIB6","first-page":"604","article-title":"The top 50 prescription medications dispensed in pharmacies in 2007","volume":"56","author":"Wynn","year":"2008","journal-title":"Gen Dent"},{"issue":"9326","key":"10.1111\/j.1751-7141.2009.00063.x-BIB7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group.","year":"2002","journal-title":"Lancet"},{"issue":"21","key":"10.1111\/j.1751-7141.2009.00063.x-BIB8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1111\/j.1751-7141.2009.00063.x-BIB9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1742-7843.2006.pto_193.x","article-title":"Muscle symptoms associated with statins: a series of twenty patients","volume":"98","author":"Soininen","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1545968305277167","article-title":"Underappreciated statin-induced myopathic weakness causes disability","volume":"19","author":"Dobkin","year":"2005","journal-title":"Neurorehabil Neural Repair"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1532-5415.2007.01071.x","article-title":"Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults","volume":"55","author":"Agostini","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1111\/j.1751-7141.2009.00063.x-BIB13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2362.2007.01805.x","article-title":"Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients","volume":"37","author":"Guazzi","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2004.06.014","article-title":"Statin myotoxicity is associated with changes in the cardiopulmonary function","volume":"177","author":"Phillips","year":"2004","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(99)00352-4","article-title":"Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients","volume":"150","author":"Paolisso","year":"2000","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10545-007-0449-6","article-title":"Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation","volume":"30","author":"Fisher","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"809","key":"10.1111\/j.1751-7141.2009.00063.x-BIB17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/pgmj.69.809.197","article-title":"The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers","volume":"69","author":"Head","year":"1993","journal-title":"Postgrad Med J"},{"issue":"8934","key":"10.1111\/j.1751-7141.2009.00063.x-BIB18","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Pederson","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/taap.1997.8131","article-title":"Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro","volume":"145","author":"Flint","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"10.1111\/j.1751-7141.2009.00063.x-BIB21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins","volume":"25","author":"Urso","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1111\/j.1751-7141.2009.00063.x-BIB22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","article-title":"Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia","volume":"100","author":"Young","year":"2007","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1111\/j.1751-7141.2009.00063.x-BIB23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.106.118331","article-title":"Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum\/mitochondria Ca2+ -release system","volume":"321","author":"Liantonio","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2007.12.010","article-title":"New insights into mechanisms of statin-associated myotoxicity","volume":"8","author":"Sirvent","year":"2008","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1152\/japplphysiol.01276.2004","article-title":"Skeletal muscle fatigue, strength, and quality in the elderly: the Health ABC Study","volume":"99","author":"Katsiaras","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1751-7141.2009.00063.x-BIB27","first-page":"99","volume-title":"ACSM\u00e2\u0080\u0099s Guidelines for Exercise Testing and Prescription","author":"American College of Sports Medicine","year":"2006"},{"issue":"3","key":"10.1111\/j.1751-7141.2009.00063.x-BIB28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.aje.a112608","article-title":"Physical activity as an index of heart attack risk in college alumni","volume":"108","author":"Paffenbarger","year":"1978","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1111\/j.1751-7141.2009.00063.x-BIB29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill pain questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1111\/j.1751-7141.2009.00063.x-BIB30","doi-asserted-by":"crossref","unstructured":"30 Tan G , Jensen MP , Thornby JI , Shanti BF . Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004;5:133\u00e2\u0080\u0093137.","DOI":"10.1016\/j.jpain.2003.12.005"},{"issue":"1","key":"10.1111\/j.1751-7141.2009.00063.x-BIB31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia","volume":"151","author":"Bradford","year":"1991","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1111\/j.1751-7141.2009.00063.x-BIB32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","article-title":"Lipid-lowering drugs and risk of myopathy: a population-based follow-up study","volume":"12","author":"Gaist","year":"2001","journal-title":"Epidemiology"},{"issue":"18","key":"10.1111\/j.1751-7141.2009.00063.x-BIB33","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archinte.1996.00440170097011","article-title":"Safety and tolerability of cholesterol lowering with simvastatin during 5\u00e2\u0080\u0083years in the Scandinavian Simvastatin Survival Study","volume":"156","author":"Pedersen","year":"1996","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1111\/j.1751-7141.2009.00063.x-BIB34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"10.1111\/j.1751-7141.2009.00063.x-BIB35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005344-200208000-00001","article-title":"Muscular side effects of statins","volume":"40","author":"Sinzinger","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1111\/j.1751-7141.2009.00063.x-BIB36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200022060-00003","article-title":"HMG-CoA reductase inhibitors and myotoxicity","volume":"22","author":"Ucar","year":"2000","journal-title":"Drug Saf"},{"issue":"14","key":"10.1111\/j.1751-7141.2009.00063.x-BIB37","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1111\/j.1751-7141.2009.00063.x-BIB38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u00e2\u0080\u0093a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7141.2009.00063.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T07:23:58Z","timestamp":1625556238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7141.2009.00063.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1111\/j.1751-7141.2009.00063.x","relation":{},"ISSN":["1520-037X","1751-7141"],"issn-type":[{"value":"1520-037X","type":"print"},{"value":"1751-7141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}